AminoChain, a New York based developer of a blockchain platform connecting medical institutions, raised $5m in seed funding.
The round, which brought total funding raised to date to $7M, was led by Andreessen Horowitz, with participation from Cercano.
The company intends to use the funds to expand operations and its development efforts.
Founded by Caspar Barnes, AminoChain connects worldwide inventories of bio-sample and research data, to power the next generation of pre-clinical research economies. Medical institutions can add users to query their sample and data collections, maintain ownership of their assets and IP, and build their network of collaborators on the platform.
The Specimen Center is the first application built on AminoChain, and biobanks are the first institutions being connected. These are just the first examples of what applications can be built and how big the network can be. Medical bodies in the AminoChain network will be able to benefit from decentralized applications in clinical recruitment, clinical trial management, decentralized AI and federated learning, to name a few examples.
Their vision is to build an HIPAA and GDPR compliant blockchain for the healthcare industry – a platform on which any company, network, non-profit, or lone scientist can source and build with compliant healthcare data.
FinSMEs
27/09/2024